Cargando…

Increased Cell‐surface Urokinase in Advanced Ovarian Cancer

Urokinase‐type plasminogen activator (uPA), uPA receptors, and cathepsin B were quantitatcd by using an immunological method, enzyme‐linked immunosorbent assay, and amidolytic activity assays in 15 malignant and 10 benign epithelial ovarian tumors. The levels of uPA and uPA receptors, as well as cat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Hiroshi, Moniwa, Nobuhiko, Sugimura, Motoi, Shinohara, Hiromitsu, Ohi, Hidekazu, Terao, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919317/ https://www.ncbi.nlm.nih.gov/pubmed/8340251 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02023.x

Ejemplares similares

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.
por: Kobayashi, H., et al.
Publicado: (1993)

Inactivation of Human Tumor Cell Pro‐urokinase by Granulocyte Elastase
por: Kanayama, Naohiro, et al.
Publicado: (1990)

Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
por: Kobayashi, H., et al.
Publicado: (1993)

Association between intrapleural urokinase monotherapy and treatment failure in patients with pleural infection: a retrospective cohort study
por: Taniguchi, Jumpei, et al.
Publicado: (2023)

Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
por: Bifulco, Katia, et al.
Publicado: (2014)

Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity
por: Stillfried, Gillian E, et al.
Publicado: (2007)

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
por: Kobayashi, H., et al.
Publicado: (1992)

Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase.
por: Schwartz-Albiez, R., et al.
Publicado: (1992)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release
por: Li, Shijie, et al.
Publicado: (2019)

Intrapleural Urokinase Injection after Medical Thoracoscopy for Empyema and Complicated Para-Pneumonic Effusion: A Case Series
por: Ugajin, Motoi, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review
por: Kobayashi, Hiroshi
Publicado: (2022)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Urokinase and macrophages in tumour angiogenesis.
por: Hildenbrand, R., et al.
Publicado: (1995)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin
Publicado: (1988)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy
por: Yu, W., et al.
Publicado: (1997)

Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas
por: Ulisse, Salvatore, et al.
Publicado: (2010)

Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer
por: Kobayashi, Satoshi, et al.
Publicado: (2019)

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
por: Masucci, Maria Teresa, et al.
Publicado: (2022)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase
Publicado: (1988)

The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface
por: Gorrasi, Anna, et al.
Publicado: (2014)

Urokinase Receptor Counteracts Vascular Smooth Muscle Cell Functional Changes Induced by Surface Topography
por: Kiyan, Yulia, et al.
Publicado: (2013)

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells
por: Kenny, Susan, et al.
Publicado: (2008)

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
por: Hindy, George, et al.
Publicado: (2022)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.
por: Kobayashi, H., et al.
Publicado: (1995)

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants
Publicado: (1989)

Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α(6)β(1)-integrin and urokinase plasminogen activator receptor expression
por: Sawai, Hirozumi, et al.
Publicado: (2006)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Application of Molecular Modeling to Urokinase Inhibitors Development
por: Sulimov, V. B., et al.
Publicado: (2014)

Role of Urokinase Receptor in Tumor Progression and Development
por: Noh, Hyangsoon, et al.
Publicado: (2013)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Binding of urokinase to specific receptor sites on human breast cancer membranes.
por: Needham, G. K., et al.
Publicado: (1987)

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
por: Baart, V. M., et al.
Publicado: (2020)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
por: Kobayashi, Shin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c5iv6jdga7707e8fd2ddff8gf6